Brief: Xbrane Biopharma AB - Re-Submits BLA For Ranibizumab Biosimilar To FDA

Xbrane Biopharma AB

31/12/2024 08:02

Dec 31 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * XBRANE BIOPHARMA AB - RE-SUBMITS BLA FOR RANIBIZUMAB
BIOSIMILAR
TO FDA

Source text:  ID:nMFN5R8gcV 
Further company coverage:  XBRANE.ST 

 ((Reuters.Briefs@thomsonreuters.com;))